Replies to post #334579 on Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

Painfully aware of that being a partial-truth.

See- current Q p.31:

Revenue



We generated revenue of $0 and $0.4 million for the three months ended September 30, 2020 and 2019, respectively. Revenue during the three months ended September 30, 2019 represented the initial non-refundable payment from the exclusive license agreement signed with Alfasigma S.p.A., a global pharmaceutical company (see Note 7. Exclusive License Agreement to the condensed consolidated financial statements).

It's a little insane to me though, that a company that's been in existence since 2005 has only managed a handful of statistically insignificant trails and some pre-clinical tests... and a single 'deal'

15yrs of what... ?

Lots of 'Leo apologists' here and not much accountability.
Businesses exist to make money within this sector.

To-date IPIX has only cost shareholders money, if they're of the long-term variety.

Not funding the company properly out of the gate was mistake #1.

Not running trials with endpoints to target not just the indications but also specific 'interested' prospective partners is an ongoing issue.

Years of PR's concerning 'partnership negotiations' etc, and nothing ever coming to fruition is concerning.

...and yeah this certainly isn't 'the investment for me', but it's not due to the product, as much as it's due to a grossly incompetent management suite. Rather... entity.

There's no such thing as 'bad teams', only bad leaders.

We'll see what happens with COVID... fingers are crossed.

But you certainly are exactly nobody to decide what 'investments are for me' or aren't for me. I've done my DD related to this, and currently in WAY too deep to walk.

If you think Leo has done an amazing job in driving shareholder value since 2005, then I'd question your personal level of investment here, and your understanding of what qualifies as an 'economically sound investment'.

...and there are other funding mechanisms available to them. It's up to mgmnt to utilize them to greatest-effect to progress the products in a timely and effective manner. Grants, partnerships etc. How's that going so far?

Current Q, p.28 (again):

An earlier grant application was unsuccessful. At the time of that grant filing deadline, the only research data available was limited to non-human Vero cells. Subsequent to the filing, human cell line experiments were completed and the data is now available. Additional grant applications incorporating the new data are planned for submission before the end of 2020.

Are you aware that ipix doesn’t have any revenues and that they either have to borrow money or dilute their stock. These trials aren’t free. If this makes you uncomfortable then maybe this isn’t the investment for you.